Global & Disaster Medicine

Lassa Fever Case Report: Combination therapy with intravenous ribavirin and oral favipiravir

July 1st, 2017

ClinInfectDis

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever

Vanessa N. Raabe, et al.

DOI:

https://doi.org/10.1093/cid/cix406
Published:
22 June 2017
Abstract
Two patients with Lassa fever are described who are the first human cases treated with a combination of ribavirin and favipiravir. Both patients survived but developed transaminitis and had prolonged detectable virus RNA in blood and semen, suggesting that the possibility of sexual transmission of Lassa virus should be considered.
This entry was posted on Saturday, July 1st, 2017 at 4:36 am and is filed under Lassa Fever .
You can follow any responses to this entry through the RSS 2.0 feed.   Both comments and pings are currently closed.

Comments are closed.

Categories

Recent Posts

Archives

Admin